THAP10 and nasopharyngeal carcinoma: Future research should validate findings in larger cohorts, explore pathway functionality via in vitro/in vivo models (e.g., qPCR validation of CAPN14/THAP10 in NPC tissues and CRISPR knockout assays), and integrate multiomics data to deepen mechanistic understanding.